For decades, injections into the eye have remained the primary way of treating retinal vascular diseases.
Injections, though effective, require patients to endure frequent and often uncomfortable appointments, wasting time and money.
Millions struggle with blurred vision caused by retinal conditions where there are no effective non-invasive treatments.